Error: Could not add to watchlist. X

Synvista Therapeutics Inc

+ Watchlist
SYNI:US
OTC US
Price not available for SYNI:US
USD
Volume
0
Previous Close
0.000
52Wk Range
0.000 - 0.001
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-6.790
Market Cap (USD)
-
Shares Outstanding (m)
2.586
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Synvista Therapeutics Inc. discovers and develops pharmaceutical products for the treatment of the complications of diabetes and age-related diseases. The Company's proprietary technology focuses on advanced glycosylation end-products formed as a result of circulating blood glucose reacting with proteins.
ADDRESS
221 West Grand Avenue
Montvale, NJ 07645
United States
PHONE
1-201-934-5000
  • Noah Berkowitz
    President/CEO/Secretary
  • Jacob Victor
    Exec Dir:Product Devt
Show More